Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Carcinoma, Squamous Cell 1Adenocarcinoma Of Esophagus 1

Interventions

Paclitaxel 6Radiotherapy 5Fluorouracil 5Cisplatin 4Taxes 3Specimen Handling 3Radiation 2Erlotinib Hydrochloride 2Endoscopy, Digestive System 2Endoscopy 2trastuzumab biosimilar HLX02 1rubitecan 1romidepsin 1oblimersen 1obeticholic acid 1cixutumumab 1bryostatin 1 1alvocidib 1adavosertib 1Trastuzumab 1Ramucirumab 1Radiofrequency Ablation 1PF-05280014 1Oxaliplatin 1Ontruzant 1Ogivri 1Nivolumab 1Neoadjuvant Therapy 1Microarray Analysis 1Magnetic Resonance Spectroscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Adenocarcinoma Of Esophagus × Esophagectomy × Clear all
NCT03223662 2018-10-30

Metabolomic and BH3 Profiling of Esophageal Cancers: Identification of Novel Assessment Methods of Treatment Response for Precision Therapy

National Institutes of Health Clinical Center (CC)

Phase 2 Terminated
2 enrolled 6 charts
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Carcinoma, Squamous Cell, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡